The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source
Abstract
Continuous evaluation of drug safety is needed following approval to determine adverse events (AEs) in patient populations with diverse backgrounds. Spontaneous reporting systems are an important source of information for the detection of AEs not identified in clinical trials and for safety assessments that reflect the real-world use of drugs in specific populations and clinical settings. The use of spontaneous reporting systems is expected to detect drug-related AEs early after the launch of a new drug. Spontaneous reporting systems do not contain data on the total number of patients that use a drug; therefore, signal detection by disproportionality analysis, focusing on differences in the ratio of AE reports, is frequently used. In recent years, new analyses have been devised, including signal detection methods focused on the difference in the time to onset of an AE, methods that consider the patient background and those that identify drug–drug interactions. However, unlike commonly used statistics, the results of these analyses are open to misinterpretation if the method and the characteristics of the spontaneous reporting system cannot be evaluated properly. Therefore, this review describes signal detection using data mining, considering traditional methods and the latest knowledge, and their limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saito, T., & Rehmsmeier, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118432 · Cited by 5,309
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Dynamic itemset counting and implication rules for market basket data
Brin, S., Motwani, R., Ullman, J. D., & Tsur, S. (1997) · Proceedings of the 1997 ACM SIGMOD international conference on Management of data - SIGMOD '97 · doi:10.1145/253260.253325 · Cited by 1,951
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
A Bayesian neural network method for adverse drug reaction signal generation
Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050466 · Cited by 1,476
van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.668 · Cited by 1,372
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Sakaeda, T., Tamon, A., Kadoyama, K., & Okuno, Y. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.6048 · Cited by 1,048
Quantitative signal detection using spontaneous ADR reporting
Bate, A., & Evans, S. J. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1742 · Cited by 912
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Szarfman, A., Machado, S. G., & O??Neill, R. T. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00001 · Cited by 700
Dynamic itemset counting and implication rules for market basket data
Brin, S., Motwani, R., Ullman, J. D., & Tsur⋆, S. (1997) · ACM SIGMOD Record · doi:10.1145/253262.253325 · Cited by 639
VigiBase, the WHO Global ICSR Database System: Basic Facts
Lindquist, M. (2008) · Drug Information Journal · doi:10.1177/009286150804200501 · Cited by 587
arules- A Computational Environment for Mining Association Rules and Frequent Item Sets
Hahsler, M., Grün, B., & Hornik, K. (2005) · Journal of Statistical Software · doi:10.18637/jss.v014.i15 · Cited by 552
Textbook of Adverse Drug Reactions.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-5-667_1 · Cited by 337
Harpaz, R., DuMouchel, W., LePendu, P., Bauer-Mehren, A., Ryan, P., & Shah, N. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.24 · Cited by 333
Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
Magro, L., Moretti, U., & Leone, R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.631910 · Cited by 287
Pariente, A., Gregoire, F., Fourrier-Reglat, A., Haramburu, F., & Moore, N. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00007 · Cited by 268
Hornik, K. (2005) · Journal of Statistical Software · doi:10.18637/jss.v014.i12 · Cited by 268
Empirical bayes screening for multi-item associations
DuMouchel, W., & Pregibon, D. (2001) · Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/502512.502526 · Cited by 266
Lindquist, M., St??hl, M., Bate, A., Edwards, I. R., & Meyboom, R. H. B. (2000) · Drug Safety · doi:10.2165/00002018-200023060-00004 · Cited by 230
Norén, G. N., Bate, A., Orre, R., & Edwards, I. R. (2006) · Statistics in Medicine · doi:10.1002/sim.2473 · Cited by 205
A statistical methodology for drug–drug interaction surveillance
Norén, G. N., Sundberg, R., Bate, A., & Edwards, I. R. (2008) · Statistics in Medicine · doi:10.1002/sim.3247 · Cited by 199
Quantitative Methods in Pharmacovigilance: Focus on Signal Detection
Hauben, M., & Zhou, X. (2003) · Drug Safety · doi:10.2165/00002018-200326030-00003 · Cited by 177
Hartnell, N. R., & Wilson, J. P. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.8.743.36068 · Cited by 172
Mining multi-item drug adverse effect associations in spontaneous reporting systems
Harpaz, R., Chase, H. S., & Friedman, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s9-s7 · Cited by 171
Vilar, S., Friedman, C., & Hripcsak, G. M. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx010 · Cited by 159
van Puijenbroek, E., Egberts, T. C. G., Heerdink, E. R., et al. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000215 · Cited by 131
Detecting signals of drug–drug interactions in a spontaneous reports database
Thakrar, B. T., Grundschober, S. B., & Doessegger, L. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02900.x · Cited by 124
van Puijenbroek, E., Egberts, T. C. G., Meyboom, R. H. B., & Leufkens, H. G. M. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00957.x · Cited by 122
Noguchi, Y., Tachi, T., & Teramachi, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01319 · Cited by 109
Self-citationA Likelihood Ratio Test Based Method for Signal Detection With Application to FDA’s Drug Safety Data
Huang, L., Zalkikar, J. N., & Tiwari, R. C. (2011) · Journal of the American Statistical Association · doi:10.1198/jasa.2011.ap10243 · Cited by 101
Comparison of data mining methodologies using Japanese spontaneous reports
Kubota, K., Koide, D., & Hirai, T. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.964 · Cited by 91
Maneenil, G., Kemp, M. W., Kannan, P. S., Kramer, B. W. W., Saito, M., Newnham, J. P., Jobe, A. H., & Kallapur, S. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119281 · Cited by 81
An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
Wang, H., Hochberg, A. M., Pearson, R. K., & Hauben, M. (2010) · Drug Safety · doi:10.2165/11584390-000000000-00000 · Cited by 71
Influence of the MedDRA® hierarchy on pharmacovigilance data mining results
Pearson, R. K., Hauben, M., Goldsmith, D. I., Gould, A. L., Madigan, D., O’Hara, D. J., Reisinger, S. J., & Hochberg, A. M. (2009) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2009.01.001 · Cited by 70
Commonality of Drug-associated Adverse Events Detected by 4 Commonly Used Data Mining Algorithms
Sakaeda, T., Kadoyama, K., Minami, K., & Okuno, Y. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.7967 · Cited by 62
Pham, M., Cheng, F., & Ramachandran, K. M. (2019) · Drug Safety · doi:10.1007/s40264-018-00792-0 · Cited by 57
Signal Detection of Adverse Drug Reactions
FUJITA, T. (2009) · Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · doi:10.3820/jjpe.14.27 · Cited by 51
Hasegawa, S., Ikesue, H., Nakao, S., Shimada, K., Mukai, R., Tanaka, M., Matsumoto, K., Inoue, M., Satake, R., Yoshida, Y., et al. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5108 · Cited by 47
Noguchi, Y., Ueno, A., Otsubo, M., Katsuno, H., Sugita, I., Kanematsu, Y., Yoshida, A., Esaki, H., Tachi, T., & Teramachi, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00197 · Cited by 45
Self-citationGosho, M., Maruo, K., Tada, K., & Hirakawa, A. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2233-3 · Cited by 36
Yue, Z., Shi, J., Jiang, P., & Sun, H. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3626 · Cited by 35
Zheng, C., & Xu, R. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2468-8 · Cited by 35
Heo, S., & Jung, I. (2020) · Statistics in Medicine · doi:10.1002/sim.8745 · Cited by 35
Raschi, E., Poluzzi, E., Koci, A., Antonazzo, I. C., Marchesini, G., & Ponti, F. D. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.006 · Cited by 33
Dijkstra, L., Garling, M., Foraita, R., & Pigeot, I. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4970 · Cited by 31
Stobaugh, D. J., Deepak, P., & Ehrenpreis, E. D. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.04.031 · Cited by 30
Susuta, Y., & Takahashi, Y. (2014) · Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · doi:10.3820/jjpe.19.39 · Cited by 25
Noguchi, Y., Takaoka, M., Hayashi, T., Tachi, T., & Teramachi, H. (2020) · Epilepsia · doi:10.1111/epi.16626 · Cited by 24
Self-citationOpen Access Pharmacovigilance Databases: Analysis of 11 Databases
Fouretier, A., Malriq, A., & Bertram, D. (2016) · Pharmaceutical Medicine · doi:10.1007/s40290-016-0146-6 · Cited by 15
Moumouni, A. N. A., Robin, P., Hillaire-Buys, D., & Faillie, J. (2018) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12334 · Cited by 15
Andreaggi, C. A., Novak, E., Mirabile, M., Sampathkumar, S., Gray, M. P., He, M.-Q., & Kane-Gill, S. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5105 · Cited by 15
Noguchi, Y., Esaki, H., Murayama, A., Sugioka, M., Koyama, A., Tachi, T., & Teramachi, H. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02794-y · Cited by 12
Self-citationNoguchi, Y., Nagasawa, H., Tachi, T., Tsuchiya, T., & Teramachi, H. (2019) · Die Pharmazie · doi:10.31083/ph.2019.9426 · Cited by 7
Self-citationLong-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Breast cancer and spironolactone: an observational postmarketing study
Sabatier, P., Amar, J., Montastruc, F., Rousseau, V., Chebane, L., Bouhanick, B., & Montastruc, J. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02740-y · Cited by 5
Metadata
- Authors
- Noguchi, Y., Tachi, T., & Teramachi, H.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-08-27
- Volume
- 22
- Issue
- 6
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W3193337461
- Cited by
- 285
- References
- 56
- FWCI
- 79.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.